PFL-002

N/A

Report date: 2026/02/03 10:09:14

Base Information

Drug NamePFL-002
Drug Alias NameVERT-002PFL-002PFL-002/VERT-002
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionHepatocyte growth factor receptor degraders
TargetsHepatocyte growth factor receptor
Therapy Area/IndicationsSolid tumoursNeoplasm MetastasisCarcinoma, Non-Small-Cell Lung
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumUnited StatesTaiwan +[11] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesVertical Bio AG
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesPierre Fabre LaboratoriesVertical Bio AGPierre Fabre (Shanghai) Management Consulting Co Ltd +[4] 
Inactive CompaniesN/A
Active IndicationsSolid tumoursNeoplasm MetastasisCarcinoma, Non-Small-Cell Lung
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A